balsalazide
Ligand Summary
a mesalamine 5-aminosalicylate prodrug; 99% of ingested drug remains intact through the stomach and is delivered to and activated in the colon; used for inflammatory bowel disease, ulcerative colitis and radiation-induced proctosigmoiditis but avoided in patients with known hypersensitivity reaction to salicylates or mesalamine
UNII: P80AL8J7ZP
ChEMBL: CHEMBL1201346
DrugCentral: 284
LyCHI: J4Z2ZD967UB2
Target Activities
4 Activities
Items per page:
1 – 4 of 4
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
INHIBITOR | ||||||
INHIBITOR | ||||||
INHIBITOR | ||||||
AGONIST | ||||||